Rachel M. Slade, Ph.D.*

Associate« back

  • J.D., University of Utah, 2008
  • Ph.D., Chemistry, University of Oregon, 1995
  • B.S., Chemistry, University of Minnesota, 1989
  • B.S., Biochemistry, University of Minnesota
  • Utah, 2009
  • U.S. Patent and Trademark Office (Reg. No. 64,951)
  • *Not licensed in Oregon





Dr. Slade’s practice focuses on patent preparation and prosecution, including the coordination of international patent strategies. She has experience counseling clients to effectively tailor their IP strategies to address business goals, including performing due diligence, patentability, and freedom-to-operate analyses. Additionally, Dr. Slade worked as a research chemist in biotech for more than 10 years prior to becoming an attorney, and is an inventor on multiple patents.


Dr. Slade has extensive experience drafting and prosecuting patent applications which incorporate chemical technologies. She has more than a decade of practical experience in the biotech industry, and combines her extensive background as a laboratory chemist and inventor with her legal expertise to provide practical guidance to clients in the chemical, biotechnical, materials, and medical device industries.


Michael Best & Friedrich, Salt Lake City, UT
Associate | 2014 – 2016

Stoel Rives, LLP, Salt Lake City, UT
Associate | 2009 – 2014
Summer Associate | 2008

University of Utah, Salt Lake City, UT
Legal Intern, Technology Commercialization Office | 2007 – 2008

Myriad Pharmaceuticals, Inc., Salt Lake City, UT
Scientist, Medicinal Chemistry | 2000 – 2006

SIDDCO, Tucson, AZ
Scientific Fellow, Chemistry | 1998 – 2000

Darwin Molecular Corporation, Bothell, WA
Scientist, Chemistry | 1995 – 1998

  • Member, American Intellectual Property Law Association
  • Member, Intellectual Property Law Section, Utah State Bar
  • Member, American Chemical Society
  • Member, David K. Winder IP Inn of Court
  • Slade, RM (2015). Frontiers in Precision Medicine: Exploring Science and Policy Boundaries, Patenting Precision Medicine. University of Utah S.J. Quinney College of Law
  • Slade, RM (2013). How Changes in the America Invents Act Affects Tech Companies. The Enterprise Business Magazine
  • Akunda, JK1; Lao, HC; Lee, CA; Sessoms, AR; Slade, RM; Langenbach, R (2004). Genetic Deficiency or Pharmacological Inhibition of Cyclooxygenase-1 or -2 Induces Mouse Keratinocyte Differentiation in vitro and in vivo. FASEB J
  • Slade, RM; Phillips, MA; Berger, JG (1998). Application of an Almost Traceless Linker to the Synthesis of 2-Alkylthiobenzimidazole Combinatorial Libraries, Molecular Diversity
  • Slade, RM; Branchaud, BP (1998). Cross-Coupling of Alkyl Cobaloximes with Maleic Anhydrides. Basic Studies and Applications to the Synthesis of Chaetomellic Acid A Anhydride and C-Glycosyl Maleic Anhydrides, Journal of Organic Chemistry
  • Slade, RM; Branchaud, BP (1996). Oxidative Addition of py(dmgH)2Co-Na* to a Ribofuranosyl Bromide: An Unusual Reaction with the Cobaloxime Ligand, Organometallics
  • Slade, RM (1995). Dissertation: A Radical Synthesis of Carbacephem Antibiotics and the Development of Cobaloxime-Mediated Syntheses of Substituted Maleic Anhydride Derivatives
  • Branchaud, BP; Slade, RM (1994). A Cobaloxime-Mediated Synthesis of the Ras Famesyl-Protein Transferase Inhibitor Chaetomellic Acid A, Tetrahedron Letters
  • Branchaud, BP; Slade, RM; Janisse, SK (1993). A Cobaloxime-Mediated Radical Route to Butenolides, Tetrahedron Letters